CIR S.p.A.
Italy · IT0000070786 · reports in EUR · Europe
The answers
From the annual report for the year to Dec 31, 2024. Each line says what it is based on.
- Is it growing?Fair
- Revenue +1.6% in the year to Dec 31, 2024, on the year before.
- Is it a good business?Good
- It earned 17% on its shareholders' equity in the year to Dec 31, 2024.
- Is it safe?Fair
- Equity is 39% of its assets, and operations brought in cash in the year.
- Is the price fair?n/a
- Not answered: no exchange publishes this company's price for free reuse, so there is no P/E here.
The year
Year to Dec 31, 2024, consolidated, in EUR.
€1.8B
revenue
5.5%
operating margin
€132M
net profit
Year by year
As filed; an earlier year can differ from its own report when the company restated it.
| Dec 2020 | Dec 2021 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|
| Revenue | €1.8B | €2.0B | €1.8B | €1.8B |
| Operating profit | €8M | €81M | €67M | €100M |
| Net profit to shareholders | €16M | €18M | €33M | €132M |
| Earnings per share | €13.90 | €15.10 | €0.03 | €0.12 |
| Cash from operations | €172M | €207M | €123M | €181M |
| Cash | €425M | €306M | €150M | €131M |
| Total assets | €3.5B | €3.3B | €3.2B | €2.8B |
| Equity | €988M | €983M | €1.0B | €1.1B |
What they do
In the company's own words, from the annual report.
nella sanità con il gruppo KOS e nella componentistica per auto con il gruppo Sogefi.
Source: the company’s annual financial report in ESEF, via filings.xbrl.org (XBRL International). Listed shares from ESMA’s FIRDS register; ESMA does not endorse this site. Ryufin computed the answers and ratios from the filed figures.